Recruiting IBS Studies in Doral
Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with predominant diarrhea (IBS-D) in adult patients. Th...
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
This is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C wh...
About IBS Clinical Trials in Doral
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder causing abdominal pain, bloating, and altered bowel habits. It affects 10-15% of the global population. Management includes dietary changes (low FODMAP diet), stress management, and medications targeting specific symptoms.
There are currently 2 ibs clinical trials recruiting participants in Doral, FL. These studies are seeking a combined 630 participants. Research is being sponsored by CinPhloro Pharma, LLC, Ardelyx. Clinical trial participation is free and participants receive study-related medical care at no cost.
IBS Clinical Trials in Doral — FAQ
Are there ibs clinical trials in Doral?
Yes, there are 2 ibs clinical trials currently recruiting in Doral, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Doral?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Doral research site will contact you about next steps.
Are clinical trials in Doral free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Doral studies also compensate for your time and travel.
What ibs treatments are being tested?
The 2 active trials in Doral are testing new therapies including novel drugs, biologics, and treatment approaches for ibs.
Data updated March 2, 2026 from ClinicalTrials.gov